Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. BSMO 1-2018

   Wuhan Createrna Science and Technology Co., Ltd

   Basket tumors

   phase 2 · small molecule · active

   1 trial →

2. BT8009, Zelenectide Pevedotin

   BICYCLE THERAPEUTICS

   NECTIN4 Amplified Advanced Breast Cancer

   phase 2 · small molecule · active

   1 trial →

3. BXCL701

   BioXcel Therapeutics

   Metastatic Pancreatic Ductal Adenocarcinoma

   phase 2 · small molecule · active

   1 trial →

4. BXCL701 plus Pembrolizumab

   BioXcel Therapeutics

   Prostate Cancer

   phase 2 · small molecule · completed

   1 trial →

5. Bactrim + compresse for Chronic Lymphocytic Leukemia

   Fondazione Telethon ETS

   Chronic Lymphocytic Leukemia

   phase 2 · small molecule · active

   1 trial →

6. Balugrastim

   Teva Pharma GmbH

   Solid Tumors

   phase 2 · small molecule · terminated

   1 trial →

7. Bavencio 20 mg/mL concentrate for solution for infusion

   Disc Medicine

   locally advanced urothelial cancer.

   phase 2 · small molecule · active

   1 trial →

8. Becotatug Vedotin

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Head and Neck Squamous Cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

9. Becotatug Vedotin

   The First People's Hospital of Lianyungang

   Nasopharyngeal Carcinoma (NPC)

   phase 2 · small molecule · active

   1 trial →

10. Becotatug Vedotin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Penile Cancer

    phase 2 · small molecule · active

    1 trial →

11. Belzutifan

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Renal Cell

    phase 2 · small molecule · active

    1 trial →

12. Bemarituzumab

    Prime Medicine

    Gastric Cancer

    phase 2 · mab · completed

    1 trial →

13. Bemarituzumab + Flot regimen

    United Therapeutics Europe Ltd

    Gastric and Gastro-oesophageal Junction (GEJ) Adenocarcinomas

    phase 2 · small molecule · terminated

    1 trial →

14. Bempegaldesleukin

    Nektar Therapeutics UK Limited

    Urinary Bladder Neoplasm

    phase 2 · mab · completed

    1 trial →

15. Bendamustine

    Adaptive Biotechnologies Corp

    Lymphoma

    phase 2 · small molecule · active

    1 trial →

16. Bendamustine

    Teva Pharma GmbH

    Mantle Cell Lymphoma

    phase 2 · small molecule · completed

    1 trial →

17. Bendamustine

    Teva Pharma GmbH

    Leukemia

    phase 2 · small molecule · completed

    1 trial →

18. Bendamustine hydrochloride

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma (NHL)

    phase 2 · small molecule · completed

    1 trial →

19. Benmelstobart

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

20. Berubicin hydrochloride

    Rani Therapeutics Holdings

    central nervous system (CNS) lymphomas

    phase 2 · small molecule · active

    1 trial →

21. Bevacizumab

    United Therapeutics Europe Ltd

    Metastatic Melanoma

    phase 2 · mab · completed

    1 trial →

22. Bevacizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

23. Bevacizumab

    ONCOLYTICS BIOTECH INC

    Ras-mutated Metastatic Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

24. Bevacizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Colorectal Neoplasms

    phase 2 · small molecule · terminated

    1 trial →

25. Bevacizumab

    The First People's Hospital of Lianyungang

    Lung, Carcinoma

    phase 2 · small molecule · active

    1 trial →

26. Bevacizumab

    United Therapeutics Europe Ltd

    Colorectal Adenocarcinoma

    phase 2 · mab · completed

    1 trial →

27. Bevacizumab

    The First People's Hospital of Lianyungang

    Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

28. Bevacizumab combined with Oxaliplatin and TAS-102

    The First People's Hospital of Lianyungang

    Advanced Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

29. Bexarotene

    LIGAND PHARMACEUTICALS INC

    Sarcoma, Kaposi

    phase 2 · small molecule · completed

    1 trial →

30. Bexarotene

    LIGAND PHARMACEUTICALS INC

    Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

31. Bexarotene (targretin)

    LIGAND PHARMACEUTICALS INC

    Carcinoma, Non-small-cell Lung

    phase 2 · small molecule · terminated

    1 trial →

32. Bexmarilimab

    Lacuna Pharma Pty Ltd

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

33. Bezuclastinib in combination with sunitinib

    Cogent Biosciences

    Gastrointestinal Stromal Tumors

    phase 2 · small molecule · active

    1 trial →

34. Bicalutamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Neoplasms

    phase 2 · small molecule · active

    1 trial →

35. BinD19

    The First People's Hospital of Lianyungang

    Relapsed B-cell Acute Lymphoblastic Leukemia

    phase 2 · mab · active

    1 trial →

36. Binimetinib

    United Therapeutics Europe Ltd

    Locally Advanced Pancreatic Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

37. Binimetinib

    United Therapeutics Europe Ltd

    Metastatic Colorectal Carcinoma

    phase 2 · small molecule · completed

    1 trial →

38. Bispecific antibody-based combined with CAR-T cell therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    B-cell Non-Hodgkin Lymphoma

    phase 2 · small molecule · active

    1 trial →

39. Blinatumomab

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

40. Blinatumomab

    Takeda

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

    phase 2 · mab · active

    1 trial →

41. Blinatumomab

    The First People's Hospital of Lianyungang

    B-cell Acute Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

42. Blinatumomab

    BEONE MEDICINES AUS PTY LTD

    B Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

43. Blinatumomab

    Amgen

    B Precursor Acute Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

44. Blinatumomab SC2

    Amgen

    Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+) B-Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

45. Blinatumomab plus Reduced-dose Chemotherapy

    The First People's Hospital of Lianyungang

    Precursor B-Cell Acute Lymphoblastic Leukemia

    phase 2 · small molecule · active

    1 trial →

46. Blood test

    Yang Xiaotian

    Cancer of Colon

    phase 2 · other · completed

    1 trial →

47. Bortezomib

    Takeda

    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)

    phase 2 · small molecule · completed

    1 trial →

48. Bortezomib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Plasma Cell Leukemia

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions